---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-065303"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:38:06.864389+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kintara Therapeutics terminates CSO Dennis Brown; directors defer fees; CEO gets $30K/month retention

## Summary
- CSO Dennis Brown terminated effective Nov 20, 2023; will continue as consultant at ≤$350/hour month-to-month.
- Board of Directors agrees to defer all director fees indefinitely to reduce costs.
- CEO Robert Hoffman receives retention payment of $30,000 per month starting Nov 1, 2023.

## SEC filing metadata
- accession: 0000950170-23-065303
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017023065303/0000950170-23-065303-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017023065303/ktra-20231120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-065303
- JSON: https://secwatch.observer/filing/0000950170-23-065303.json
- Plain text: https://secwatch.observer/filing/0000950170-23-065303.txt

## Key facts
- Executive change
  Dennis Brown was terminated as Chief Scientific Officer at TuHURA Biosciences, Inc./NV.
  - Action: terminated
  - Role: Chief Scientific Officer
  source text: on November 20, 2023, Dennis Brown was terminated from his position as the Company’s Chief Scientific Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017023065303/0000950170-23-065303-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.